CellaVision AB (OSTO:CEVI) Interest Expense : kr-3.8 Mil (TTM As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is CellaVision AB Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. CellaVision AB's interest expense for the three months ended in Mar. 2024 was kr -2.2 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was kr-3.8 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. CellaVision AB's Operating Income for the three months ended in Mar. 2024 was kr 38.8 Mil. CellaVision AB's Interest Expense for the three months ended in Mar. 2024 was kr -2.2 Mil. CellaVision AB's Interest Coverage for the quarter that ended in Mar. 2024 was 17.28. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CellaVision AB Interest Expense Historical Data

The historical data trend for CellaVision AB's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellaVision AB Interest Expense Chart

CellaVision AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-1.50

-2.55

-1.87

-2.34

-3.26

CellaVision AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-1.68	-3.84	-1.50	3.77	-2.25

CellaVision AB Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-3.8 Mil.

CellaVision AB (OSTO:CEVI) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CellaVision AB's Interest Expense for the three months ended in Mar. 2024 was kr-2.2 Mil. Its Operating Income for the three months ended in Mar. 2024 was kr38.8 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was kr25.5 Mil.

CellaVision AB's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	38.819	/	-2.247
	=	17.28

The higher the ratio, the stronger the company's financial strength is.

CellaVision AB (OSTO:CEVI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (OSTO:CEVI) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

0MR5:UK C26:Germany

Address

Mobilvagen 12, Lund, SWE, 22362

Website

https://www.cellavision.com

CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers.

CellaVision AB (OSTO:CEVI) Headlines

No Headlines